|
Volumn 345, Issue 23, 2001, Pages 1655-1659
|
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
ADULT;
AGED;
ARTICLE;
BLOOD TOXICITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG RESPONSE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
KIDNEY CANCER;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
METASTASIS;
MULTICENTER STUDY;
NEPHRECTOMY;
PERFORMANCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL TIME;
TREATMENT INDICATION;
ACTUARIAL ANALYSIS;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
INTERFERON ALFA-2B;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEPHRECTOMY;
SURVIVAL ANALYSIS;
|
EID: 0035818877
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMoa003013 Document Type: Article |
Times cited : (1491)
|
References (28)
|